Solventum Corp. (SOLV)
Operating profit margin
Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | ||
---|---|---|---|---|---|---|
Operating income (ttm) | US$ in thousands | 1,535,500 | 1,564,000 | 1,596,000 | 1,626,000 | 1,658,000 |
Revenue (ttm) | US$ in thousands | 8,208,500 | 8,236,000 | 8,146,000 | 8,101,000 | 8,115,500 |
Operating profit margin | 18.71% | 18.99% | 19.59% | 20.07% | 20.43% |
March 31, 2024 calculation
Operating profit margin = Operating income (ttm) ÷ Revenue (ttm)
= $1,535,500K ÷ $8,208,500K
= 18.71%
Solventum Corp.'s operating profit margin has been showing a decreasing trend over the past five quarters. The operating profit margin decreased from 20.43% in the first quarter of 2023 to 18.71% in the first quarter of 2024. This trend indicates that the company's ability to generate profit from its core operations has been declining over time. It would be important for Solventum Corp. to closely monitor its operating expenses and revenue generation strategies to reverse this trend and improve its operating profit margins in the future.
Peer comparison
Mar 31, 2024
Company name
Symbol
Operating profit margin
Solventum Corp.
SOLV
18.71%
3M Company
MMM
-27.93%
Artivion Inc
AORT
1.73%
Baxter International Inc
BAX
3.00%
Becton Dickinson and Company
BDX
10.08%
Boston Scientific Corp
BSX
16.77%
DexCom Inc
DXCM
16.59%
Embecta Corp
EMBC
15.96%
Glaukos Corp
GKOS
-42.44%
Globus Medical
GMED
8.49%
Haemonetics Corporation
HAE
6.35%